Single Lot of Dexmedetomidine Recalled After Contamination With Lidocaine

Fresenius Kabi USA is voluntarily recalling a single lot of dexmedetomidine hydrochloride in 0.9% sodium chloride injection, 200 mcg/50 mL (4 mcg /mL), 50-mL fill in a 50-mL vial due to the presence of a trace amount of lidocaine. This recall is being performed to the user level with the knowledge of the FDA.